Enzychem Lifesciences Sets Record Date for Extraordinary General Meeting

Enzychem Lifesciences has set June 29, 2026 as the record date to determine shareholders entitled to vote at the extraordinary general meeting, following a board resolution on June 12, 2026.
This is a routine procedure under Article 14 of the company's articles of incorporation, and no closure period of the shareholder register is separately disclosed due to the electronic registration law.
The record date setting is a standard step for convening a shareholder meeting and does not involve any capital changes or dividend-related matters that directly impact shareholder value.
[AI Summary]Enzychem Lifesciences' establishment of a record date for an extraordinary general meeting is a regular procedural step for governance transparency. This disclosure does not entail any share issuance or capital raising, resulting in a neutral impact on existing shareholder value and growth outlook. Investors should note trading dates between the board resolution and record date, but there are no fundamental investment risks.